Cellectar BioSciences announces annual shareholder meeting notice

• Cellectar Biosciences will hold its annual shareholder meeting virtually on July 7, 2026.
• Shareholders are set to vote on electing two Class III directors, including Andrew Gu and Douglas J. Swirsky.
• The meeting agenda also includes expanding the 2021 Stock Incentive Plan by 1,000,000 shares, approving a non-binding executive pay proposal, and authorizing the exercise of warrants covering up to 39,618,078 shares.
• Other items include ratifying Deloitte & Touche as auditor for the year ending Dec. 31, 2026, and a proposal to adjourn the meeting if needed to seek additional votes on the warrant exercise item.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-063259), on May 18, 2026, and is solely responsible for the information contained therein.